你是否曾听说过晚期癌症患者因骨转移而承受的巨大痛苦？近日，中国国家药监局药品审评中心（CDE）官网传来好消息，科伦博泰1类新药SKB107注射液获批临床，拟开发用于晚期实体瘤骨转移。这一消息让无数患者看到了希望，也让医学界对靶向放射性药物（RDC）的研发充满了期待。

(the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a radionuclide-drug conjugate (RDC) drug SKB107 (formerly TBM-001 ...

Biotech’s radionuclide-drug conjugate SKB107 receives China NMPA approval to treat bone metastases in solid tumours: Chengdu, China Friday, March 28, 2025, 15:00 H ...

Rochester Drug Cooperative (RDC) is one of the 10 largest pharmaceutical distributors in the US. This case, in which two former executives are implicated, is the first case of its kind in the country.

CHENGDU, China, March 25, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the ...

SKB107 is the first company RDC drug clinical project. SKB107 is jointly developed by the Company and Professor Chen Yue's team of the Affiliated Hospital of Southwest Medical University (the ...